Want to track NOV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novo Nordisk A/S (NOV) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.45T
Trailing P/E (ttm) 11.64
Forward P/E -
PEG ratio 2.32
Price/Sales (ttm) 4.11
Price/Book (mrq) 6.11
Enterprise Value/Revenue 4.4
Enterprise Value/EBITDA 8.39
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 9.73K
Average volume (90 days) 9.36K
Price summary
52-Week low 30.29
52-Week high 54.86
Beta -
50-Day moving average 41.17
200-Day moving average 38.44
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 11.7
Trailing annual dividend yield 0.0383%
5-Year annual dividend yield -
Payout ratio 0.45
Dividend Date 19 Aug 2025
Ex-Dividend Date 15 Aug 2025
Last split factor 2:1
Last split Date 13 Sep 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.35%
Operating margin 0.43%
Operational effectiveness
Return on assets 0.2%
Return on equity 0.59%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 74.4
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 26.3
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 10.16
Total debt (mrq) -
Total Debt/Equity (mrq) 0.63
Current ratio (mrq) 0.87%
Book value per share (mrq) 49.97
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
